Invention Grant
US08822518B2 Compounds as antagonists or inverse agonists of opioid receptors for treatment of addiction
有权
化合物作为拮抗剂或用于治疗成瘾的阿片受体的反向激动剂
- Patent Title: Compounds as antagonists or inverse agonists of opioid receptors for treatment of addiction
- Patent Title (中): 化合物作为拮抗剂或用于治疗成瘾的阿片受体的反向激动剂
-
Application No.: US14103893Application Date: 2013-12-12
-
Publication No.: US08822518B2Publication Date: 2014-09-02
- Inventor: David John Cowan , Andrew Lamont Larkin , Cunyu Zhang , David Lee Musso , Gary Martin Green , Rodolfo Cadilla , Paul Kenneth Spearing , Michael Joseph Bishop , Jason Daniel Speake
- Applicant: GlaxoSmithKline LLC
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Robert H. Brink
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61P25/00 ; A61P25/30 ; A61P25/36
Abstract:
Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.
Public/Granted literature
- US20140100255A1 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors Public/Granted day:2014-04-10
Information query
